JP3156933B2 - 縮合チオフェン化合物およびその医薬用途 - Google Patents

縮合チオフェン化合物およびその医薬用途

Info

Publication number
JP3156933B2
JP3156933B2 JP51595799A JP51595799A JP3156933B2 JP 3156933 B2 JP3156933 B2 JP 3156933B2 JP 51595799 A JP51595799 A JP 51595799A JP 51595799 A JP51595799 A JP 51595799A JP 3156933 B2 JP3156933 B2 JP 3156933B2
Authority
JP
Japan
Prior art keywords
benzothieno
benzodiazepine
methyl
fluoro
methylpiperazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP51595799A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO1999011647A1 (ja
Inventor
康志 清尾
寛 田中
利行 小原
謙二 橋本
成剛 藤村
秀記 堀内
浩 安松
是一 木村
Original Assignee
ウェルファイド株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27322564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP3156933(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ウェルファイド株式会社 filed Critical ウェルファイド株式会社
Publication of JPWO1999011647A1 publication Critical patent/JPWO1999011647A1/ja
Application granted granted Critical
Publication of JP3156933B2 publication Critical patent/JP3156933B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP51595799A 1997-09-02 1998-08-31 縮合チオフェン化合物およびその医薬用途 Expired - Fee Related JP3156933B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP23670097 1997-09-02
JP9-236700 1997-09-02
JP27777197 1997-10-09
JP9-277771 1997-10-09
JP10-165725 1998-06-12
JP16572598 1998-06-12
PCT/JP1998/003915 WO1999011647A1 (en) 1997-09-02 1998-08-31 Fused thiophene compounds and medicinal use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2000289527A Division JP4354106B2 (ja) 1997-09-02 2000-09-22 縮合チオフェン化合物およびその医薬用途

Publications (2)

Publication Number Publication Date
JPWO1999011647A1 JPWO1999011647A1 (ja) 2000-10-17
JP3156933B2 true JP3156933B2 (ja) 2001-04-16

Family

ID=27322564

Family Applications (2)

Application Number Title Priority Date Filing Date
JP51595799A Expired - Fee Related JP3156933B2 (ja) 1997-09-02 1998-08-31 縮合チオフェン化合物およびその医薬用途
JP2000289527A Expired - Fee Related JP4354106B2 (ja) 1997-09-02 2000-09-22 縮合チオフェン化合物およびその医薬用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2000289527A Expired - Fee Related JP4354106B2 (ja) 1997-09-02 2000-09-22 縮合チオフェン化合物およびその医薬用途

Country Status (16)

Country Link
US (2) US6271225B1 (cg-RX-API-DMAC10.html)
EP (1) EP1016664B1 (cg-RX-API-DMAC10.html)
JP (2) JP3156933B2 (cg-RX-API-DMAC10.html)
KR (1) KR20010021989A (cg-RX-API-DMAC10.html)
CN (1) CN1268949A (cg-RX-API-DMAC10.html)
AT (1) ATE244245T1 (cg-RX-API-DMAC10.html)
AU (1) AU739385B2 (cg-RX-API-DMAC10.html)
BR (1) BR9814042A (cg-RX-API-DMAC10.html)
CA (1) CA2302409A1 (cg-RX-API-DMAC10.html)
DE (1) DE69816102D1 (cg-RX-API-DMAC10.html)
HU (1) HUP0003718A3 (cg-RX-API-DMAC10.html)
IL (1) IL134812A0 (cg-RX-API-DMAC10.html)
NO (1) NO20001049L (cg-RX-API-DMAC10.html)
NZ (1) NZ503484A (cg-RX-API-DMAC10.html)
RU (1) RU2197491C2 (cg-RX-API-DMAC10.html)
WO (1) WO1999011647A1 (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6399582B1 (en) 1999-04-16 2002-06-04 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
US6751036B2 (en) * 2000-08-04 2004-06-15 Seagate Technology Llc Tuning track density for data storage device
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
EP2363396A1 (en) * 2001-06-11 2011-09-07 Virochem Pharma Inc. Thiophene derivatives as antiviral agents for flavivirus infection
ES2285227T3 (es) 2002-08-05 2007-11-16 Eli Lilly And Company Arilbenzodiazepinas sustituidas con piperazina.
DE60332482D1 (de) 2002-12-10 2010-06-17 Virochem Pharma Inc Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen
US20040236181A1 (en) * 2003-04-01 2004-11-25 Olympus Corporation In-body information acquiring apparatus and power-supply circuit
CA2536107A1 (en) * 2003-09-09 2005-03-24 Eli Lilly And Company Substituted piperazines of azepines, oxazepines, and thiazepines
RU2248205C1 (ru) * 2003-09-18 2005-03-20 Открытое акционерное общество "Щелковский витаминный завод" Лекарственное средство в виде желатиновой капсулы
EP1713486A4 (en) * 2003-12-02 2009-04-29 Sheldon Leslie James COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY
WO2005063771A1 (en) * 2003-12-22 2005-07-14 Teva Pharmaceutical Industries Ltd Methods of preparing olanzapine
US7807828B2 (en) * 2005-08-11 2010-10-05 Hypnion, Inc. Olanzapine analogs and methods of use thereof
SG176488A1 (en) * 2006-11-15 2011-12-29 Virochem Pharma Inc Thiophene analogues for the treatment or prevention of flavivirus infections
PL395468A1 (pl) 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego
JP6551671B2 (ja) * 2015-08-11 2019-07-31 国立大学法人 熊本大学 アルツハイマー治療薬
US12365696B2 (en) 2019-05-10 2025-07-22 Dana-Farber Cancer Institute, Inc. Small-molecule focal adhesion kinase (FAK) inhibitors

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017400A1 (en) 1993-12-23 1995-06-29 Allelix Biopharmaceuticals Inc. N-heterobicyclyl-piperazinyl or-piperadinyl tricyclic derivatives useful as dopamine receptor ligands
WO1996018621A1 (en) 1994-12-12 1996-06-20 Allelix Biopharmaceuticals Inc. Alkyl-substituted compounds having dopamine receptor affinity
WO1996018623A1 (en) 1994-12-12 1996-06-20 Allelix Biopharmaceuticals Inc. Benzyl-substituted compounds having dopamine receptor affinity

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140242B (nl) 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
CH468400A (de) 1965-12-23 1969-02-15 Sandoz Ag Verfahren zur Herstellung neuer Thieno(2,3-b)(1,5)benzothiazepin-4-on-Verbindungen
US3683084A (en) 1969-02-06 1972-08-08 Jean Schmutz Basically substituted heterocycles as anti-emetics
US3726977A (en) 1969-02-06 1973-04-10 Sandoz Ag 2-NITRO-11-(1-PIPERAZINYL)-DIBENZ (b,f) (1,4) OXAZEPINES COMPOSITIONS IN THE TREATMENT OF DEPRESSION
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
SU629879A3 (ru) * 1974-11-26 1978-10-25 Лилли Индастриз Лимитед, (Фирма) Способ получени тиено(1,5) бензодиазепинов или их солей
US4115568A (en) 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
US4172831A (en) 1974-11-26 1979-10-30 Lilly Industries Limited Thieno-benzodiazepines
GB1533236A (en) * 1975-11-24 1978-11-22 Lilly Industries Ltd Thieno(1,5)benzodiazepine intermediates
US4157444A (en) 1978-03-13 1979-06-05 American Cyanamid Company 10-(Piperazinyl)thieno[3,4-b][1,5]benzoxazepines and 10-(piperazinyl)thieno[3,4-b][1,5]benzothiazepines
GB9009229D0 (en) 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5700445A (en) 1994-12-12 1997-12-23 Allelix Biopharmaceuticals, Inc. N-methyl piperazine compounds having dopamine receptor affinity
US5602124A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5576314A (en) 1994-12-12 1996-11-19 Allelix Biopharmaceuticals Inc. Bicyclic nonane and decane compounds having dopamine receptor affinity
US5561127A (en) 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017400A1 (en) 1993-12-23 1995-06-29 Allelix Biopharmaceuticals Inc. N-heterobicyclyl-piperazinyl or-piperadinyl tricyclic derivatives useful as dopamine receptor ligands
WO1996018621A1 (en) 1994-12-12 1996-06-20 Allelix Biopharmaceuticals Inc. Alkyl-substituted compounds having dopamine receptor affinity
WO1996018623A1 (en) 1994-12-12 1996-06-20 Allelix Biopharmaceuticals Inc. Benzyl-substituted compounds having dopamine receptor affinity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J.Med.Chem.,Vol.25,No.10(1982)P.1133−1140

Also Published As

Publication number Publication date
US6271225B1 (en) 2001-08-07
DE69816102D1 (de) 2003-08-07
NZ503484A (en) 2001-10-26
ATE244245T1 (de) 2003-07-15
IL134812A0 (en) 2001-04-30
NO20001049L (no) 2000-04-03
HUP0003718A3 (en) 2002-11-28
NO20001049D0 (no) 2000-03-01
KR20010021989A (ko) 2001-03-15
EP1016664A1 (en) 2000-07-05
HUP0003718A2 (hu) 2001-09-28
AU739385B2 (en) 2001-10-11
US20020042411A1 (en) 2002-04-11
EP1016664B1 (en) 2003-07-02
CN1268949A (zh) 2000-10-04
CA2302409A1 (en) 1999-03-11
WO1999011647A1 (en) 1999-03-11
RU2197491C2 (ru) 2003-01-27
JP2001072684A (ja) 2001-03-21
AU8889098A (en) 1999-03-22
US6455521B1 (en) 2002-09-24
EP1016664A4 (en) 2001-01-24
BR9814042A (pt) 2000-10-03
JP4354106B2 (ja) 2009-10-28

Similar Documents

Publication Publication Date Title
JP4354106B2 (ja) 縮合チオフェン化合物およびその医薬用途
JP3239364B2 (ja) 骨粗鬆症治療薬およびジアゼピン化合物
US4115574A (en) Benzodiazepine derivatives
KR102092147B1 (ko) P2x4 수용체 길항제
JPWO1999011647A1 (ja) 縮合チオフェン化合物およびその医薬用途
JP3130502B2 (ja) 新規なキノリンスルフィド誘導体、その製造方法及び用途
JPH09291034A (ja) 縮合ピリジン化合物およびその医薬としての用途
US20070010537A1 (en) Fused pyramidine derivative and use thereof
SK96494A3 (en) Piperazine and piperidine derivatives, and their use as antipsychotic
CN102245612A (zh) 新型三环衍生物或其药物可接受的盐、其制备方法和含有它们的药物组合物
JPWO2009157196A1 (ja) アミド化合物
CA2536313A1 (en) Fused pyrimidine derivative and use thereof
CN101679272B (zh) 作为腺苷a3受体配体的三唑并[1,5-a]喹啉类
CA2565683C (en) Substituted azepine derivatives as serotonin receptor modulators
WO1997003986A1 (en) Fused triazole compounds
FI67550B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2,10-dihydro-4-piperazinyl-pyrazolo(3,4-b)(1,5)bensodiazepinderivat
CS236753B2 (en) Processing of thieno (1,5) benzodiazepine derivatives
US4172831A (en) Thieno-benzodiazepines
JP2007505106A (ja) アゼピン、オキサゼピン、およびチアゼピンの置換ピペラジン
TWI495640B (zh) 苯並氮呯化合物
KR20010022658A (ko) 3-치환된 3,4,5,7-테트라히드로-피롤로[3'4':4,5]티에노[2,3-d]피리미딘 유도체, 그의 제법 및 5ht길항제로서의 용도
NZ540768A (en) Benzamide derivatives as oxytocin agonists and vasopressin antagonists
JP2005097276A (ja) 縮合ピリミジン誘導体およびその用途
JP5599802B2 (ja) 縮合複素環誘導体およびその用途
HK1029340A (en) Fused thiophene compounds and medicinal use thereof

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees